In vitro study demonstrates real-time electrochemical tracking of glucose consumption across cancer cell lines, highlighting metabolic shifts tied to malignancy and cell cycle phase.
Cellular uptake of glucose is the first step for glucose metabolism that is closely related to the physiological activities of cells, it is effective to monitor the glucose consumption of cell culture medium in real time. Herein, a sensitive and selective electrochemical glucose sensor was developed by coating a molecularly imprinted polymer (MIP) layer on a carbon nanoframework co-loaded with NiO and MnO (Ni&Mn/CNFs). The Ni&Mn/CNFs were prepared via electrospinning and subsequent carbonization, and the MIP layer was electropolymerized using glucose as the template, creating specific recognition cavities. The bimetallic oxide synergistically enhances electrocatalytic activity, while the MIP layer endows excellent anti-interference capability. The sensor shows a linear response from 10 μM to 300 μM, with a sensitivity of 4.28 μA·log e (μM −1 )·cm −2 and a detection limit of 0.87 μM. Real-time monitoring of glucose consumption in cell culture media revealed that the highly malignant cancer cells (e.g., U87 and H1975) exhibit higher glucose metabolism than less aggressive cells (e.g., MCF-7 and HEK-293T), correlating metabolic levels with invasive/proliferative potential. Moreover, it is found that glucose consumption is higher during the S phase of the cell cycle, reflecting increased energy demand for DNA replication. This work provides a simple and reliable strategy for monitoring glucose metabolism in real-time and screening drugs targeting glucose metabolism.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: